Wikidata

(Q66400090)

English

Study of Pts With Philadelphia Chromosome-Pos ALL With Comb of Ibrutinib, Dasatinib, and Prednisone

clinical trial

In more languages

Statements

title
A Phase 1 Study of Combining Ibrutinib, Dasatinib and Prednisone in Patients 60 Years or Older With Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia (English)
0 references
start time
28 September 2016
0 references
end time
9 January 2018
0 references
number of participants
0
0 references
research intervention
prednisone
0 references
dasatinib
0 references
minimum age
60 year
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q66400090&oldid=1858878511"